Memory-enhancing activity of Thespesia populnea in rats

Pharmaceutical Biology

Volumn 45, Issue 4, 2007, Pages 267-273

  Vasudevan, Mani ^a   Parle, Milind ^a  

^a GURU JAMBHESHWAR UNIVERSITY OF SCIENCE AND TECHNOLOGY   (India)

Author keywords

Amnesia; Elevated plus maze; Hebb Williams maze; Memory; Thespesia populnea

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTIOXIDANT; CHOLINESTERASE INHIBITOR; DIAZEPAM; HYPOCHOLESTEROLEMIC AGENT; PLANT EXTRACT; SCOPOLAMINE; THESPESIA POPULNEA EXTRACT; UNCLASSIFIED DRUG;

AGING; AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG EFFECT; MALE; MEDICINAL PLANT; MEMORY; NONHUMAN; RAT; THESPESIA POPULNEA; WISTAR RAT;

CORDEAUXIA EDULIS; MALVACEAE; RATTUS; THESPESIA POPULNEA;

EID: 34347373291     PISSN: 13880209     EISSN: 17445116     Source Type: Journal    
DOI: 10.1080/13880200701214631     Document Type: Article

References (50)

1. Adelman AM, Daly MP (2005): Initial evaluation of the patient with suspected dementia. Am Fam Physician 71: 1745-1750.
2. Agnolli A, Martucci N, Manna V, Conti L (1983): Effect of cholinergic and anticholinergic drugs on short term memory in electroencephalographic study. Clin Neuro Pharmacol 6: 311-323.
3. Akhila A, Rani K (1993): Biosynthesis of gossypol in Thespesia populnea. Phytochemistry 33: 335-340.
4. Anonymous (1995): The Wealth of India. New Delhi, India, Publication and Information Directorate (CSIR), pp. 223-275.
5. Balaraman R, Shingala, J (2002): Nootropic. Indian J Pharmacol 34: 439-440.
6. Benhaim P, Mathes SJ, Hunt TK, Scheuenstuhl H, Benz CC (1994): Induction of neutrophil Mac-1 integrin expression and superoxide production by the medicinal plant extract gossypol. Inflammation 18: 443-458.
7. Berr C (2002): Oxidative stress and cognitive impairment in the elderly. J Nutr Health Aging 6: 261-266.
8. Bhattacharya SK, Upadhyay SN, Jaiswal AK (1993): Effect of piracetam on electroshock induced amnesia and decrease in brain acetylcholine in rats. Indian J Exp Biol 31: 822-824.
9. Bickford PC, Gould T, Briederick L, Chadman K, Polloch A, Young D, Shukitt-Hale B, Joseph J (2000): Antioxidants-rich diets improve cerebellar physiology and motor learning in aged rats. Brain Res 886: 211-217.
10. Breitner JCS (1996): The role of anti-inflammatory drugs in the prevention and treatment of Alzheimer's disease. Annu Rev Med 47: 401-411.
11. Butterfield DA, Lauderback CM (2002): Lipid peroxidation and protein oxidation in Alzheimer's disease: Potential causes and consequences involving amyloid-beta peptide-associated free radical oxidative stress. Free Radic Biol Med 32: 1050-1060.
12. Dhingra D, Parle M, Kulkarni SK (2004): Memory enhancing activity of Glycyrrhiza glabra in mice. J Ethnopharmacol 91: 361-365.
13. Dhingra D, Parle M, Kulkarni SK (2005): Genetic basis of Alzheimer's disease. Indian J Pharm Sci 67: 409-413.
14. Floyd RA, Hensley K (2002): Oxidative stress in brain aging. Implications for therapeutics of neurodegenerative disease. Neurobiol Aging 23: 795-807.
15. Gauthier S, Emre M, Farlow MR, Bullock R, Grossberg GT, Potkin SG (2003): Strategies for continued successful treatment of Alzheimer's disease: Switching cholinesterase inhibitors. Curr Med Res Opin 19: 707-714.
16. Ghelardini C, Galeotti N, Barboloni A, Furukawa S (1998): Memory facilitation and stimulation of endogenous nerve growth factor synthesis by the acetylcholine releaser PG-9. Jpn J Pharmacol 78: 245-251.
17. Ghosh K, Bhattacharya TK (2004): Preliminary study on the anti-implantation activity of compounds from the extracts of seeds of Thespesia populnea. Indian J Pharmacol 36: 288-291.
18. Higashida A, Ogawa N (1987): Difference in the acquisition process and the effect of scopolamine on radial maze performance in the strains of rats. Pharmacol Biochem Behav 27: 483-489.
19. Ilavarasan R, Vasudevan M, Anbazhagan S, Venkataraman S (2003a): Antioxidant activity of Thespesia populnea bark extracts against carbon tetrachloride-induced liver injury in rats. J Ethnopharmacol 87: 227-230.
20. Ilavarasan R, Vasudevan M, Anbazhagan S, Venkataraman S, Sridhar SK (2003b): Hepatoprotective activity of Thespesia populnea bark extracts against carbon tetrachloride-induced liver toxicity in rats. Nat Prod Sci 9: 83-86.
21. Itoh J, Nabeshima T, Kameyama T (1990): Utility of an elevated plus maze for evaluation of nootripics, scopolamine and electroconvulsive shock. Psychopharmacology 101: 27-33.
22. Johnson JI, Gandhidasan R, Murugesan R (1999): Cytotoxicity and superoxide anion generation by some naturally occurring quinines. Free Radic Biol Med 26: 1072-1078.
23. Mashkovskii MD, Glushkov RG (2001): Drugs for the treatment of Alzheimer's disease. Pharm Chem J 35: 179-182.
24. McGeer EG, McGeer PL (1999): Brain inflammation and the therapeutic implications. Curr Pharm Design 5: 821-836.
25. Mori T, Paris D, Town T, Rojiani AM, Sparks DL, Delledonne A, Crawford F, Asdullah LI, Humphrey JA, Dickson DW, Mullan MJ (2001): Cholesterol accumulation in sanile plaques of Alzheimer's disease patient and in transgenic APPsw mice. J Neuropath Exp Neur 60: 778-785.
26. Murthy RSR, Basu DK, Murti VVS (1981): Antifertility activity of (+) gossypol. Curr Sci 50: 64-66.
27. Nabeshima T (1993): Behavioral aspects of cholinergic transmission: Role of basal forebrain cholinergic system in learning and memory. Prog Brain Res 98: 405-411.
28. Olney JW(1990): Excitotoxic amino acids and neurophychiatric disorders. Ann Rev Pharmacol Toxicol 30: 47-71.
29. Parle M, Singh N (2004): Animal models for testing memory. Asia Pacific J Pharmacol 16: 101-120.
30. Parle M, Dhingra D, Kulkarni SK (2004): Neurochemical basis of learning and memory. Indian J Pharm Sci 66: 371-376.
31. Parle M, Vasudevan M, Singh N (2005): Swim everyday to keep dementia away. J Sport Sci Med 4: 37-46.
32. Peng WH, Hsich MT, Wu CR (1997): Effect of long term administration of berberine of scopolamine induced amnesia in rats. Jpn J Pharmacol 74: 261-265.
33. Perry G, Cash AD, Smith MA (2002): Alzheimer disease and oxidative stress. J Biomed Biotech 2: 120-123.
34. Potkin SG, Anand R, Fleming K, Alva G, Keator D, Carreon D, Messing J, Wu JC, Hartman R, Fallon JH (2001): Brain metabolic and clinical effects of rivastigmine in Alzheimer's disease. Int J Neuropsychopharmacol 4: 223-230.
35. Puglielli L, Tanzi RE, Kovacs DM (2003): Alzheimer's disease: the cholesterol connection. Nature Med Neurosci 6: 345-351.
36. Qian S, Wang Z (1984): Gossypol: A potential antifertility agent for males. Ann Rev Pharmacol Toxicol 24: 329-360.
37. Rao SK, Andrade C, Reddy K, Madappa KN, Thyagarajan S, Chandra S (2002): Memory protective effect of indomethacin against electroconvulsive shock-induced retrograde amnesia in rats. Biol Psychiat 51: 770-773.
38. Reddy DS, Kulkarni SK (1998): Possible role of nitric oxide in the nootropic and antiamnesic effects of neurosteroids on aging and dizocilpine-induced learning impairment. Brain Res 799: 215-229.
39. Ringman JM, Cummings JL (1999): Metrifonate: Update on a new antidementia agent. J Clin Psychiatry 60: 776-782.
40. Rogers EJ, Milhalik S, Ortiz, Shea TB (2003). Apple juice prevents oxidative stress and impaired cognitive performance caused by genetic and dietary deficiencies in mice. J Nut Health Aging 7: 1-6.
41. Sathyanarayana T, Sarita T, Balaji M, Ramesh A, Boini MK (2004): Antihyperglycemic and hypoglycemic effect of Thespesia populnea fruit in normal and alloxan-induced diabetes in rabbits. Saudi Pharm J 12: 107-111.
42. Sayre LM, Zagorski MG, Surewicz WK, Krafft GA, Perry G (1997): Mechanisms of neurotoxicity associated with amyloid beta deposition and the role of free radicals in the pathogenesis of Alzheimer's disease: A critical appraisal. Chem Res Toxicol 336: 1216-1222.
43. Shirwaikar A, Kumar AV, Krishnanand BR, Sreenivasan KK (1995): Chemical investigation and antihepatotoxic activity of Thespesia populnea. Int J Pharmacog 33: 305-310.
44. Sinclair AJ, Bayer AJ, Johnston J, Warner C, Maxwell SR (1998): Altered plasma antioxidant status in subjects with Alzheimer's disease and vascular dementia. Int J Geriatr Psychiatr 13: 840-855.
45. Sitaram N, Weingartner H, Gillin JC (1978): Human serial learning. Enhancement with arecholine and choline and impairment with scopolamine. Science 201: 247-276.
46. Sparks DL, Kuo YM, Roher A, Martin T, Lukas RJ (2000): Alterations of Alzheimer's disease in cholesterol-fed rabbit, including vascular inflammation, preliminary observations. Ann NY Acad Sci 903: 335-344.
47. Sramek JJ, Frackiewicz EJ, Cutler NR (2000): Review of acetylcholinesterase inhibitor galanthamine. Expert Opin Inv Drug 9: 2393-2402.
48. Stephan A, Laroche S, Davis S (2003): Learning deficits and dysfunctional synaptic plasticity induced by aggregated amyloid deposits in the dentate gyrus are rescued by chronic treatment with indomethacin. Eur J Neurosci 17: 1921-1927.
49. Sugimoto H, Ogura H, Arai Y, Iimura Y, Yamanishi Y (2002): Research and development of donepezil hydrochloride, a new type of anticholinesterase inhibitor. Jpn J Pharmacol 89: 7-20.
50. Vasudevan M, Parle M (2007): Pharmacological actions of Thespesia populnea relevant to Alzheimer's disease. Phytomedicine (in press).